See more : MANAC Chemical Partners Co.,Ltd (4360.T) Income Statement Analysis – Financial Results
Complete financial analysis of Stenocare A/S (STENO.CO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Stenocare A/S, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Adriatic Metals PLC (ADTLF) Income Statement Analysis – Financial Results
- BioLife Sciences Inc. (BLFE) Income Statement Analysis – Financial Results
- NRB Industrial Bearings Limited (NIBL.BO) Income Statement Analysis – Financial Results
- La Française de l’Energie S.A. (LFDE.PA) Income Statement Analysis – Financial Results
- G Mining Ventures Corp. (GMINF) Income Statement Analysis – Financial Results
Stenocare A/S (STENO.CO)
About Stenocare A/S
Stenocare A/S cultivates, produces, imports, sells, and distributes prescription-based medical cannabis products in the Danish and European markets. It offers medical cannabis oil products. Stenocare A/S was incorporated in 2017 and is based in Randers, Denmark.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 3.76M | 4.49M | 1.58M | 198.45K | 8.78M | 4.14M |
| Cost of Revenue | 10.18M | 10.90M | 15.65M | 12.27M | 11.41M | 7.74M |
| Gross Profit | -6.42M | -6.41M | -14.08M | -12.07M | -2.63M | -3.59M |
| Gross Profit Ratio | -170.84% | -142.77% | -893.87% | -6,082.87% | -29.94% | -86.67% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.27M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 9.76M | 6.81M | 7.23M | 5.84M | 4.37M | 5.27M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 9.76M | 10.12M | 8.32M | 6.08M | 4.43M | 7.74M |
| Cost & Expenses | 19.70M | 21.02M | 8.32M | 6.08M | 4.43M | 7.74M |
| Interest Income | 0.00 | 16.99K | 32.16K | 31.84K | 9.42K | 0.00 |
| Interest Expense | 2.88M | 1.29M | 213.23K | 1.68M | 2.12M | 12.57K |
| Depreciation & Amortization | 3.38M | 3.31M | 1.09M | 240.65K | 58.92K | 1.40K |
| EBITDA | -12.56M | -13.20M | -12.96M | -11.80M | -6.84M | -3.60M |
| EBITDA Ratio | -334.30% | -295.80% | -822.79% | -5,945.56% | 50.39% | -86.64% |
| Operating Income | -15.95M | -16.53M | -14.05M | -12.04M | 4.37M | -3.59M |
| Operating Income Ratio | -424.36% | -368.13% | -891.83% | -6,066.82% | 49.72% | -86.67% |
| Total Other Income/Expenses | -2.88M | -1.36M | -213.68K | -1.68M | 9.14M | -12.57K |
| Income Before Tax | -18.82M | -17.89M | -14.26M | -13.72M | 2.25M | -3.61M |
| Income Before Tax Ratio | -500.89% | -398.42% | -905.37% | -6,913.16% | 25.57% | -86.98% |
| Income Tax Expense | -1.25M | -1.58M | -1.53M | -1.93M | 544.04K | -328.74K |
| Net Income | -17.57M | -16.30M | -12.73M | -11.79M | 1.70M | -3.28M |
| Net Income Ratio | -467.55% | -363.13% | -808.41% | -5,939.17% | 19.38% | -79.05% |
| EPS | -1.26 | -1.35 | -1.05 | -1.06 | 0.17 | -0.33 |
| EPS Diluted | -1.26 | -1.35 | -1.05 | -1.06 | 0.17 | -0.33 |
| Weighted Avg Shares Out | 13.94M | 12.10M | 12.09M | 11.15M | 10.22M | 10.07M |
| Weighted Avg Shares Out (Dil) | 13.94M | 12.10M | 12.09M | 11.15M | 10.07M | 10.07M |
No news found for: STENO.CO
Source: https://incomestatements.info
Category: Stock Reports